Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy

Abstract

Objective: Urocortin is a placental neuropeptide belonging to the family of corticotropin-releasing factors (CRFs), playing a role in the uteroplacental blood flow regulation through the binding to spectflc CRF receptors. Since CRF receptors are expressed in the uterine vascular bed of pregnant rats, and because urocortin has a relaxant effect on uterine vasculature, we evaluated mid-gestation plasma urocortin levels in women with impaired bloodflow through uterine arteries.

Methods: Maternal plasma urocortin was assayed by specfic radioimmunoassay and uterine artery resistance index (RI) by Doppler evaluation at 22-24 weeks'gestation in 57 healthy pregnant women, of which 29 showed a monolateral or bilateral uterine artery notch. Statistical analysis was performed by one-way analysis of variance (ANOVA), followed by post-hoc Tukey test for multiple comparison and Pearson correlation coefficient test.

Results: The mean uterine artery RI was signficantly (P <. 001) higher in women with a notch than healthy controls. Mean ± SEM maternal plasma urocortin levels were significantly (P <.001) lower in women with unilateral (52.03 ± 3.25 pg/mL) or bilateral (47.01 ± 4.16 pg/mL) uterine artery notch than in healthy control pregnant women (84.01 + 3.5 pg/mL). While no difference was found in urocortin levels between patients with unilateral or bilateral uterine artery notch, urocortin concentrations inversely correlated with the mean RI (Pearson r = -0.7318; 95% confidence interval-0.8334 to-0.5822; P <.0001).

Conclusions: The present findings suggest that reduced levels of circulating urocortin are associated with increased uterine artery resistances and support the hypothesis that urocortin may regulate uterine artery tone at mid gestation.

Keywords

Urocortin Doppler endothelium vasodilatation uterine artery

Get full access to this article

View all access options for this article.

References

1. Donaldson CJ , Sutton SW , Pemin MH , et al. Cloning and characterization of human urocortin. Endocrinology 1996;137:2167-2170.

2. Grammatopoulos DK , Chrousos GP . Functional characteristics of CRH receptors and potential clinical applications of CRHreceptor antagonists. Trends Endocrinol Metab 2002;13:436-444.

3. Parkes DG , Vaughan J , Rivier J , Vale W , May CN . Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol Heart Circ Physiol 1997;272:H2115-H2122.

4. Mackay KB , Stiefel TH , Ling N , Foster AC . Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat. Eur J Pharmacol 2003;469:111-115.

5. Cohen ML , Bloomquist W , Li D , Iyengar S . Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice. Gen Pharmacol 2000;34:371-377.

6. Yao X , He GW , Chan FL , et al. Endothelium-dependent and-independent coronary relaxation induced by urocortin. J Card Surg 2002;17:347-349.

7. Huang Y , Chan FL , Lau CW , et al. Urocortin-induced endothelium-dependent relaxation of rat coronary artery: Role of nitric oxide and K+ channels. Br J Pharmacol 2002;135:1467-1476.

8. Huang Y , Chan FL , Lau CW , et al. Roles of cyclic AMP and Ca2+-activated K+ channels in endothelium-independent relaxation by urocortin in the rat coronary artery. Cardiovasc Res 2003;57:824-833.

9. Schilling L , Kanzler C , Schmiedek P , Ehrenreich H . Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. BrJ Pharmacol 1998;125:1164-1171.

10.

10. Leitch IM , Boura AL , Botti C , Read MA , Walters WA , Smith R . Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 1998;83:4510-4513.

11.

11. Jain V , Longo M , Ai M , Saade GR , Chwalisz K , Garfield RE . Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Investig 2000;7:153-160.

12.

12. Jain V , Vedernikov YP , Saade GR , Chwalisz K , Garfield RE . Endothelium-dependent and-independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther 1999;288:407-413.

13.

13. Florio P , Severi FM , Fiore G , et al. Impaired uterine artery blood flow at mid gestation and low levels of maternal plasma corticotropin-releasing factor. J Soc Gynecol Investig 2003;10:294-297.

14.

14. Florio P , Severi FM , Ciarmela P , et al. Placental stress factors and maternal-fetal adaptive response: The corticotropin-releasing factor family. Endocrine 2002;19:91-102.

15.

15. Florio P , Vale W , Petraglia F . Urocortins in human reproduction. Peptides 2004;25:1751-1757.

16.

16. Petraglia F , Florio P , Galo R , et al. Human placenta and fetal membrane express human urocortin mRNA and peptide. J Clin Endocrinol Metab 1996;81:3807-3810.

17.

17. Florio P , Rivest S , Reis FM , et al. Lack of gestational-related changes of urocortin gene expression in human placenta. Prenat Neonat Med 1999;4:296-300.

18.

18. Watanabe F , Oki Y , Ozawa M , et al. Urocortin in human placenta and maternal plasma. Peptides 1999;20:205-209.

19.

19. Clifton VL , Qing G , Murphy VE , Schwartz J , Madsen G , Smith R . Localization and characterization of urocortin during human pregnancy. Placenta 2000;21:782-788.

20.

20. Schneider EP , Schulman H . Hypertension. In: Copel JA , Reed KL , eds. Doppler Ultrasound in Obstetrics and Gynecology. New York: Raven Press, 1995:147-155.

21.

21. Florio P , Cobellis L , Woodman J , Severi FM , Linton EA , Petraglia F . Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J Soc Gynecol Investig 2002;9:233-237.

22.

22. Severi FM , Bocchi C , Visentin A , et al. Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2002;19:225-228.

23.

23. Poston L , McCarthy AL , Ritter JM . Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 1995;65:215-239.

24.

24. Sibai BM . Hypertension in pregnancy. In: Gabbe SG , Niebyl JR , Simpson JL , eds. Obstetrics: Normal and Problem Pregnancies. New York: Churchili Livingstone; 1996:935-996.

25.

25. Greiss FC Jr . Pressure-flow relationship in the gravid uterine vascular bed. Am J Obstet Gynecol 1996;96:46-47.

26.

26. Sanz E , Fernandez N , Monge L , Climent B , Dieguez G , Garcia Villalon AL . Relaxation of rat arteries by urocortin: Effects of gender and diabetes. J Pharm Pharmacol 2003;55:783-788.

27.

27. Sanz E , Monge L , Fernandez N , Climent B , Dieguez G , Garcia Villalon AL . Mechanisms of relaxation by urocortin in renal arteries from male and female rats. Br J Pharmacol 2003;140:1003-1007.

28.

28. Coste SC , Kesterson RA , Heldwein KA , et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000;24:403-409.

29.

29. Cross JC , Hemberger M , Lu Y , et al. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol 2002;187:207-212.

30.

30. Petraglia F , Florio P , Nappi C , Genazzani AR . Peptide signaling in human placenta and membranes: autocnrne, paracnrne, and endocnrne mechanisms. Endocr Rev 1996;17:156-186.

31.

31. Petraglia F , Flonro P , Benedetto C , et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metab 1999;84:1420-1423.

32.

32. Rohde E , Furkert J , Fechner K , et al. Corticotropin-releasing hormone (CRH) receptors in the mesentenrc small artenres of rats resemble the (2)-subtype. Biochem Pharmacol 1996;52:829-833.